MITCHELL DANN is listed as an executive officer and director on 4 SEC Form D filings by 2 issuers between Aug 2009 and Sep 2015: VALENTX INC (Maple Grove, MN — biotechnology — 2009–2015; $20.3M reported sold to 32 investors) and Hemosphere, Inc. (Eden Prairie, MN — biotechnology — 2010; $9.35M reported sold to 23 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 6 years. Across those companies the filings report $29.6M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for MITCHELL DANN and found 3 differences: MITCHELL DANN's role changed at VALENTX INC: executive officer, director → director; Address moved from Carpinteria, CA to Maple Grove, MN; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.